Survey Takes Pulse of eHealth in Europe and Prescribes Wider ICT use Among Doctors

The European Commission published a pan-European survey on electronic services in healthcare (eHealth) that shows 87% of European doctors (General Practitioners) use a computer, 48% with a broadband connection. European doctors increasingly store and send patients' data such as lab reports electronically. In using such eHealth applications, doctors and medical services have already improved healthcare in Europe through, for example, more efficient administration and shorter waiting times for patients. The report also highlights where doctors could make better use of ICT to offer services such as telemonitoring, electronic prescriptions and cross border medical services.

"Europe is starting to reap the benefits of broadband connections in the eHealth Sector. I welcome the efforts made by healthcare administrations and doctors to work more efficiently," said Viviane Reding, EU Commissioner for Information Society and Media. "This diagnosis also shows that it is now time to use these electronic services much more widely as they have the potential to bring extraordinary benefits to all patients, all over Europe."

eHealth applications have a growing role in the doctor's practices, according to the 'Benchmarking ICT use among General Practitioners in Europe' survey presented today by the Commission. However, there remain significant differences in their availability and use across Europe. About 70% of European doctors use the Internet and 66% use computers for consultations. Furthermore, there are wide differences across countries: Denmark has the highest broadband penetration among General Practitioners (91%), Romania the lowest (about 5%).

Administrative patient data is electronically stored in 80% of general practices: 92% of these also electronically store medical data on diagnoses and medication; 35% electronically store radiological images. European doctors often transfer data electronically with laboratories (40%), but less to other health centres (10%).

The survey shows that the countries most advanced in ICT access and connectivity are more likely to use them for professional purposes. For example, Denmark, where high-speed internet is most widely available in Europe, sees extensive use of email communication between doctors and patients in about 60% of practices (the EU average is only 4%).

The survey also highlights areas for improvement and further deployment, such as electronic prescriptions (e-Prescribing), which is practiced by only 6% of EU General Practitioners. This is widely used in only three Member States: Denmark (97%), the Netherlands (71%) and Sweden (81%).

Telemonitoring, which allows doctors to monitor a patient's illness or manage chronic diseases remotely, is only used in Sweden (where 9% of doctors provide telemonitoring services), the Netherlands and Iceland (both about 3%). The Commission plans to report later this year on the potential and development of telemedicine.

Exchange of patient data across borders is also rare, done by only 1% of the EU's General Practitioners, and with the highest usage rate in the Netherlands (at 5%). This year the Commission plans to make recommendations on cross-border interoperability of electronic health record systems and will launch, with several countries, a project on cross-border eHealth services for patients traveling within the EU.

A majority of European doctors agree that ICT improves the quality of healthcare services that they provide. Doctors not using ICT cite a lack of training and technical support as major barriers. To spread eHealth, they ask for more ICT in medical education, more training and better electronic networking among healthcare practitioners wanting to share clinical information.

Background:
In 2004, the European Commission adopted an Action Plan to develop the use of ICT in the Health sector (IP/04/580). As a result, all Member States put in place strategies to accelerate eHealth deployment (www.ehealth-era.org). eHealth is part of the Lead Market initiative for innovation launched by the Commission in 2008 (IP/08/12).

The results of this survey, which involved almost 7,000 General Practitioners in the 3rd quarter of 2007, are related to these policy initiatives. The results will be presented in the forthcoming European eHealth Conference in Slovenia on May 6-7 (http://www.ehealth2008.si).

29 Country profiles and the final report are available at:
http://ec.europa.eu/information_society/
eeurope/i2010/benchmarking/index_en.htm

Most Popular Now

Therapy using dual immune system cells effectively…

A newly developed immunotherapy that simultaneously uses modified immune-fighting cells to home in on and attack two antigens, or foreign substances, on cancer cells was ...

Cleveland Clinic study suggests steroid nasal spra…

A recent Cleveland Clinic study found that patients who regularly use steroid nasal sprays are less likely to develop severe COVID-19-related disease, including a 20 to 2...

How to develop new drugs based on merged datasets

Polymorphs are molecules that have different molecular packing arrangements despite identical chemical compositions. In a recent paper, researchers at GlaxoSmithKline (GS...

New drug combination effective against SARS-CoV-2 …

More countries with greater resources are opening up for a more normal life. But COVID-19 and the SARS-CoV-2 virus are still a significant threat in large parts of the wo...

Sanofi to focus its COVID-19 development efforts o…

Recent positive interim results of Sanofi's mRNA-based COVID-19 vaccine candidate Phase 1/2 study confirm the company's platform robust capabilities and strategy in mRNA...

Discovery of mechanics of drug targets for COVID-1…

A team of international researchers, including McGill Professor Stéphane Laporte, have discovered the working mechanism of potential drug targets for various diseases suc...

Phase II/III trial shows Ronapreve™ (casirivimab a…

Roche (SIX: RO, ROG; OTCQX: RHHBY) today confirmed positive data from the phase II/III 2066 study, investigating Ronapreve™ (casirivimab and imdevimab) in patients hospit...

Pfizer and BioNTech receive first U.S. FDA Emergen…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the U.S. Food and Drug Administration (FDA) has authorized for emergency use a booster dose of the P...

AZD7442 request for Emergency Use Authorization fo…

AstraZeneca has submitted a request to the US Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA) for AZD7442, its long-acting antibody (LAAB) com...

Pfizer and BioNTech receive CHMP positive opinion …

Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal Products for Human Use (CHMP) of the Europea...

Boehringer Ingelheim acquires Abexxa Biologics to …

Boehringer Ingelheim announced the acquisition of Abexxa Biologics Inc., a biopharmaceutical company taking a new approach in the fields of immuno-oncology and oncology r...

GSK welcomes WHO recommendation for broad roll-out…

GlaxoSmithKline (GSK) plc welcomes and applauds the WHO recommendation for the broader deployment of GSK's RTS,S malaria vaccine to reduce childhood illness and deaths fr...